27th February 2024

Confidant Classes

for LAW | CLAT | JUDICIARY

Home | Edu NEWS | Remdesivir

Remdesivir

The US Food and Drug Administration has issued an emergency use authorization for Remdesivir, an investigational antiviral drug. With this authorization, physicians in the United States are now authorized to use the medication to treat patients with severe cases of -19.

Remdesivir is not new, was originally developed to treat Ebola and has also been laboratory tested against SARS and MERS, two other coronaviruses that infect humans in much the same way as the virus that causes COVID-19. It has never reached the approval stage for these uses, but in the past four months, scientists have desperately searched for options to help mitigate the coronavirus pandemic, and have turned to ancient drugs that could be reused.

Remdesivir has traveled an unprecedented path toward regulatory approval, making it one of the most promising treatments for COVID-19 to date. Remdesivir is not a vaccine and therefore cannot prevent infection; Instead, it works by attacking the virus once it has already spread within the body. Here is an overview of how the COVID-19 virus spreads in the human body and how the drug slows down this process.

  1. Virus enters a cell: Viruses cannot multiply without using the protein-producing machinery of a cell. Therefore, they must first enter a healthy cell. Coronaviruses, like the one caused by COVID-19, have a layer of sharp proteins that allow them to bind to cells.
  2. The virus releases the genetic code: the virus fuses with the cell and, once inside, releases a strand of RNA. Like a plan, RNA is a chain of genetic codes that has instructions for making exact copies of the virus.
  3. The genetic code is converted into proteins: tiny particles in the host cell, called ribosomes, are equipped to read genetic material. When the RNA from the virus crosses the ribosome, the ribosome produces viral proteins.
  4. Proteins make copies: Viral proteins are necessary to make copies of viral RNA, as well as other parts of the virus, such as the outer peaks and the membrane. As more and more protein and RNA chains are made, they proliferate, making exponentially more copies that fill the cell.
  5. The viral parts are assembled: the viral parts use mechanisms in the host cell to unite, forming a complete virus. Once fully assembled, the virus can leave the cell to find other healthy cells and begin the process again.
  6. Remdesivir blocks replication: Remdesivir mimics part of the viral RNA. During the copy process, it is inserted into the RNA strand. Once bound, the drug prevents further copies, leaving the RNA chain incomplete and unable to produce critical viral parts.
  7. The virus slows down: hindered by the drug, the entire replication process slows down. This means that fewer viruses are assembled. Defective viruses with partial RNA cannot replicate in other cells.

Delhi University 5 Year Law Programs Registration Begins

Delhi University has started the registration process for 5 year law programs. Candidates applying for the 5-year law programs can…
Read More

Bar Council of India proposes to hold CLAT and declares NLU Consortium a non-statutory body

The , in a supplementary affidavit filed before the Delhi High Court, proposed to conduct the Common…
Read More

DU UG 2023 Admissions Process Expected to Begin End of May

Admissions for undergraduate and graduate programs will be by CSAS (UG) 2023 and CSAS (PG) 2023. Delhi University plans to…
Read More

CUET UG 2023 Participating Universities | Central University of Karnataka

The Central Karnataka University will start admission for its undergraduate programs from May 21 this year. Admission to these UG…
Read More

AIBE XVII 2023 results published

AIBE XVII Result: Candidates who have taken the exam can now check their result on the AIBE website: allindiabarexamination.com. AIVE…
Read More

CUET PG 2023 | Six universities join the CUET PG

CUET PG 2023: Interested and eligible candidates can apply until May 5 on the official website: cuet..nic.in. The CUET PG…
Read More

AIBE XVII (17) 2023 result

Once released, candidates who have taken the AIBE XVII(17) 2023 exam will be able to check their score on the…
Read More

CUET UG 2023 Participating Universities |  Central University of Haryana

The university currently has eight schools and 34 departments that offers science and humanities programs. CUET-2023-Preparation CUET UG 2023: The…
Read More

CUET UG 2023 Participating Universities: BHU

CUET UG 2023: After Delhi University, BHU received the most applications among central universities. Here is everything you need to…
Read More

CUET PG 2023 to be held June 5-12

CUET PG 2023: Exams will be held daily from June 5-12, i.e. June 5, 6, 7, 8, 9, 10, 11,…
Read More

AatmNirbhar Bharat (4) AIBE (6) AIBE17 (4) CACP (3) CBSE (3) CORONA VACCINE (3) Coronavirus (18) COVID 19 (14) COVID19 (3) CUET (20) CUET PG (4) CUET UG (11) CUET UG 2023 (14) DU Admission (4) Facebook (5) Fiscal deficit (4) fiscal stimulus (4) FOREIGN EXCHANGE RESERVES (3) GDP (3) GI Tag (5) GI TAGS In iNDIA (3) GST (5) GST COMPENSATION (4) indian economy (20) INDO-CHINA BORDER DISPUTE (3) INDO-CHINA CONFLICT (6) INFLATION (3) JIO (5) lockdown (6) MONETARY POLICY COMMITTEE (4) MPC (5) MSP (3) NIRF (3) nobel prize 2020 (5) PMI (3) RAFALE FIGHTER JET (3) RBI (12) RBI GOVERNOR (3) RELIANCE INDUSTRIES LIMITED (4) REPO Rate (4) RIL (8) supreme court of india (5) twitter (3) UNIVERSITY OF DELHI (4) UNSC (3)

About Post Author